Unresolved issues in the analysis of F₂-isoprostanes, F₄-neuroprostanes, isofurans, neurofurans, and F₂-dihomo-isoprostanes in body fluids and tissue using gas chromatography/negative-ion chemical-ionization mass spectrometry

References

• Halliwell B, Whiteman M. Measuring reactive species and oxidative damage in vivo and in cell culture: how should you do it and what do the results mean? Br J Pharmacol 2004;142:231–255.
   PubMed Web of Science ®Google Scholar
• Niki E. Biomarkers of lipid peroxidation in clinical material. Biochim Biophys Acta 2014;1840:809–817.
   PubMed Web of Science ®Google Scholar
• Morrow JD, Hill KE, Burk RF, Nammour TM, Badr KF, Roberts LJ. A series of prostaglandin F2-like compounds are produced in vivo in humans by a non-cyclooxygenase, free radical-catalyzed mechanism. Proc Natl Acad Sci U S A 1990;87:9383–9387.
   PubMed Web of Science ®Google Scholar
• Roberts LJ, Morrow JD. Measurement of F2-isoprostanes as an index of oxidative stress in vivo. Free Radic Biol Med 2000;28:505–513.
   PubMed Web of Science ®Google Scholar
• Basu S. F2-isoprostanes in human health and diseases: from molecular mechanisms to clinical implications. Antioxid Redox Signal 2008;10:1405–1434.
   PubMed Web of Science ®Google Scholar
• Montuschi P, Barnes P, Roberts LJ. Insights into oxidative stress: the isoprostanes. Curr Med Chem 2007;14:703–717.
   PubMed Web of Science ®Google Scholar
• Vigor C, Bertrand-Michel J, Pinot E, Oger C, Vercauteren J, Le Faouder P, et al. Non-enzymatic lipid oxidation products in biological systems: Assessment of the metabolites from polyunsaturated fatty acids. J Chromatogr B Analyt Technol Biomed Life Sci 2014;964:65–78.
   PubMed Web of Science ®Google Scholar
• Milne GL, Yin H, Hardy KD, Davies SS, Roberts LJ. Isoprostane generation and function. Chem Rev 2011;111:5973–5996.
   PubMed Web of Science ®Google Scholar
• Roberts LJ, Fessel JP. The biochemistry of the isoprostane, neuroprostane, and isofuran pathways of lipid peroxidation. Chem Phys Lipids 2004;128:173–186.
   PubMed Web of Science ®Google Scholar
• Song WL, Lawson JA, Reilly D, Rokach J, Chang CT, Giasson B, FitzGerald GA. Neurofurans, novel indices of oxidant stress derived from docosahexaenoic acid. J Biol Chem 2008;283:6–16.
   PubMedGoogle Scholar
• Liu W, Morrow JD, Yin H. Quantification of F2-isoprostanes as a reliable index of oxidative stress in vivo using gas chromatography-mass spectrometry (GC-MS) method. Free Radic Biol Med 2009;47:1101–1107.
   PubMed Web of Science ®Google Scholar
• Milne GL, Sanchez SC, Musiek ES, Morrow JD. Quantification of F2-isoprostanes as a biomarker of oxidative stress. Nat Protoc 2007;2:221–226.
   PubMed Web of Science ®Google Scholar
• Tsikas D. Application of gas chromatography-mass spectrometry and gas chromatography-tandem mass spectrometry to assess in vivo synthesis of prostaglandins, thromboxane, leukotrienes, isoprostanes and related compounds in humans. J Chromatogr B Biomed Sci Appl 1998;717:201–245.
   PubMedGoogle Scholar
• Tsikas D, Zoerner AA. Analysis of eicosanoids by LC-MS/MS and GC-MS/MS: A historical retrospect and a discussion. J Chromatogr B Analyt Technol Biomed Life Sci 2014;964: 79–88.
   PubMedGoogle Scholar
• Perez-Chacon G, Astudillo AM, Balgoma D, Balboa MA, Balsinde J. Control of free arachidonic acid levels by phospholipases A2 and lysophospholipid acyltransferases. Biochim Biophys Acta 2009;1791:1103–1113.
   PubMed Web of Science ®Google Scholar
• Korbecki J, Baranowska-Bosiacka I, Gutowska I, Chlubek D. The effect of reactive oxygen species on the synthesis of prostanoids from arachidonic acid. J Physiol Pharmacol 2013; 64:409–421.
   PubMed Web of Science ®Google Scholar
• Stafforini DM. Biology of platelet-activating factor acetylhydrolase (PAF-AH, lipoprotein associated phospholipase A2). Cardiovasc Drugs Ther 2009;23:73–83.
   PubMed Web of Science ®Google Scholar
• Stafforini DM, Sheller JR, Blackwell TS, Sapirstein A, Yull FE, McIntyre TM, et al. Release of free F2-isoprostanes from esterified phospholipids is catalyzed by intracellular and plasma platelet-activating factor acetylhydrolases. J Biol Chem 2006;281:4616–4623.
   PubMed Web of Science ®Google Scholar
• Jahn U, Galano JM, Durand T. Beyond prostaglandins–chemistry and biology of cyclic oxygenated metabolites formed by free-radical pathways from polyunsaturated fatty acids. Angew Chem Int Ed Engl 2008;47:5894–5955.
   PubMed Web of Science ®Google Scholar
• Taber DF, Morrow JD, Roberts LJ. A nomenclature system for the isoprostanes. Prostaglandins 1997;53:63–67.
   PubMed Web of Science ®Google Scholar
• Rokach J, Khanapure SP, Hwang SW, Adiyaman M, Lawson JA, FitzGerald GA. Nomenclature of isoprostanes: a proposal. Prostaglandins 1997;54:853–873.
   PubMed Web of Science ®Google Scholar
• Morrow JD. The isoprostanes - unique products of arachidonate peroxidation: their role as mediators of oxidant stress. Curr Pharm Des 2006;12:895–902.
   PubMed Web of Science ®Google Scholar
• Belik J, Gonzalez-Luis GE, Perez-Vizcaino F, Villamor E. Isoprostanes in fetal and neonatal health and disease. Free Radic Biol Med 2010;48:177–188.
   PubMed Web of Science ®Google Scholar
• Galano JM, Mas E, Barden A, Mori TA, Signorini C, De Felice C, et al. Isoprostanes and neuroprostanes: total synthesis, biological activity and biomarkers of oxidative stress in humans. Prostaglandins Other Lipid Mediat 2013;107: 95–102.
   PubMed Web of Science ®Google Scholar
• Roberts LJ, Montine TJ, Markesbery WR, Tapper AR, Hardy P, Chemtob S, et al. Formation of isoprostane-like compounds (neuroprostanes) in vivo from docosahexaenoic acid. J Biol Chem 1998;273:13605–13612.
   PubMed Web of Science ®Google Scholar
• Yin H, Musiek ES, Gao L, Porter NA, Morrow JD. Regiochemistry of neuroprostanes generated from the peroxidation of docosahexaenoic acid in vitro and in vivo. J Biol Chem 2005;280:26600–26611.
   PubMedGoogle Scholar
• Taber DF, Roberts LJ. Nomenclature systems for the neuroprostanes and for the neurofurans. Prostaglandins Other Lipid Mediat 2005;78:14–18.
   PubMedGoogle Scholar
• VanRollins M, Woltjer RL, Yin H, Morrow JD, Montine TJ. F2-dihomo-isoprostanes arise from free radical attack on adrenic acid. J Lipid Res 2008;49:995–1005.
   PubMed Web of Science ®Google Scholar
• Hsieh YP, Lin CL, Shiue AL, Yin H, Morrow JD, Hsu JC, et al. Correlation of F4-neuroprostanes levels in cerebrospinal fluid with outcome of aneurysmal subarachnoid hemorrhage in humans. Free Radic Biol Med 2009;47:814–824.
   PubMed Web of Science ®Google Scholar
• Fessel JP, Porter NA, Moore KP, Sheller JR, Roberts LJ. Discovery of lipid peroxidation products formed in vivo with a substituted tetrahydrofuran ring (isofurans) that are favored by increased oxygen tension. Proc Natl Acad Sci U S A 2002;99:16713–16718.
   PubMed Web of Science ®Google Scholar
• Fessel JP, Jackson RL. Isofurans: novel products of lipid peroxidation that define the occurrence of oxidant injury in settings of elevated oxygen tension. Antioxid Redox Signal 2005;7:202–209.
   PubMedGoogle Scholar
• Taber DF, Fessel JP, Roberts LJ. A nomenclature system for isofurans. Prostaglandins Other Lipid Mediat 2004;73: 47–50.
   PubMedGoogle Scholar
• de La Torre A, Lee YY, Oger C, Sangild PT, Durand T, Lee JC, Galano JM. Synthesis, discovery, and quantitation of dihomo-isofurans: biomarkers for in vivo adrenic acid peroxidation. Angew Chem Int Ed Engl 2014;53:6249–6252.
   PubMed Web of Science ®Google Scholar
• Milne GL, Yin H, Brooks JD, Sanchez S, Jackson RL, Morrow JD. Quantification of F2-isoprostanes in biological fluids and tissues as a measure of oxidant stress. Methods Enzymol 2007;433:113–126.
   PubMed Web of Science ®Google Scholar
• Milne GL, Gao B, Terry ES, Zackert WE, Sanchez SC. Measurement of F2- isoprostanes and isofurans using gas chromatography-mass spectrometry. Free Radic Biol Med 2013;59:36–44.
   PubMed Web of Science ®Google Scholar
• Morrow JD, Frei B, Longmire AW, Gaziano JM, Lynch SM, Shyr Y, et al. Increase in circulating products of lipid peroxidation (F2-isoprostanes) in smokers. Smoking as a cause of oxidative damage. N Engl J Med 1995;332:1198–1203.
   PubMed Web of Science ®Google Scholar
• Arneson KO, Roberts LJ. Measurement of products of docosahexaenoic acid peroxidation, neuroprostanes, and neurofurans. Methods Enzymol 2007;433:127–143.
   PubMed Web of Science ®Google Scholar
• Lin CL, Hsu YT, Lin TK, Morrow JD, Hsu JC, Hsu YH, et al. Increased levels of F2-isoprostanes following aneurysmal subarachnoid hemorrhage in humans. Free Radic Biol Med 2006;40:1466–1473.
   PubMed Web of Science ®Google Scholar
• Yen HC, Wei HJ, Chen TW. Analytical variables affecting analysis of F2-isoprostanes and F4-neuroprostanes in human cerebrospinal fluid by gas chromatography/mass spectrometry. Biomed Res Int 2013;2013:810915.
   PubMedGoogle Scholar
• Ferretti A, Flanagan VP. Mass spectrometric evidence for the conversion of exogenous adrenate to dihomo-prostaglandins by seminal vesicle cyclo-oxygenase. A comparative study of two animal species J Chromatogr 1986;383:241–250.
   Google Scholar
• Mas E, Barden A, Durand T, Galano JM, Croft KD, Mori TA. Measurement of urinary F2-isoprostanes by gas chromatography-mass spectrometry is confounded by interfering substances. Free Radic Res 2010;44:191–198.
   PubMed Web of Science ®Google Scholar
• Lee CY, Jenner AM, Halliwell B. Rapid preparation of human urine and plasma samples for analysis of F2-isoprostanes by gas chromatography-mass spectrometry. Biochem Biophys Res Commun 2004;320:696–702.
   PubMed Web of Science ®Google Scholar
• Montine TJ, Quinn JF, Milatovic D, Silbert LC, Dang T, Sanchez S, et al. Peripheral F2-isoprostanes and F4-neuroprostanes are not increased in Alzheimer's disease. Ann Neurol 2002;52:175–179.
   PubMed Web of Science ®Google Scholar
• Musiek ES, Cha JK, Yin H, Zackert WE, Terry ES, Porter NA, et al. Quantification of F-ring isoprostane-like compounds (F4-neuroprostanes) derived from docosahexaenoic acid in vivo in humans by a stable isotope dilution mass spectrometric assay. J Chromatogr B Analyt Technol Biomed Life Sci 2004;799:95–102.
   PubMed Web of Science ®Google Scholar
• Mori TA, Croft KD, Puddey IB, Beilin LJ. An improved method for the measurement of urinary and plasma F2-isoprostanes using gas chromatography-mass spectrometry. Anal Biochem 1999;268:117–125.
   PubMed Web of Science ®Google Scholar
• Mas E, Barden AE, Corcoran TB, Phillips M, Roberts LJ, Mori TA. Effects of spinal or general anesthesia on F2-isoprostanes and isofurans during ischemia/reperfusion of the leg in patients undergoing knee replacement surgery. Free Radic Biol Med 2011;50:1171–1176.
   PubMed Web of Science ®Google Scholar
• Lee CY, Huang SH, Jenner AM, Halliwell B. Measurement of F2-isoprostanes, hydroxyeicosatetraenoic products, and oxysterols from a single plasma sample. Free Radic Biol Med 2008;44:1314–1322.
   PubMed Web of Science ®Google Scholar
• Lee CY, Isaac HB, Wang H, Huang SH, Long LH, Jenner AM, et al. Cautions in the use of biomarkers of oxidative damage; the vascular and antioxidant effects of dark soy sauce in humans. Biochem Biophys Res Commun 2006;344:906–911.
   PubMed Web of Science ®Google Scholar
• Lee CY, Seet RC, Huang SH, Long LH, Halliwell B. Different patterns of oxidized lipid products in plasma and urine of dengue fever, stroke, and Parkinson's disease patients: cautions in the use of biomarkers of oxidative stress. Antioxid Redox Signal 2009;11:407–420.
   PubMed Web of Science ®Google Scholar
• Lim KH, Lee CY, Earnest A, Seet RC, Halliwell B. Does radiotherapy increase oxidative stress? A study with nasopharyngeal cancer patients revealing anomalies in isoprostanes measurements. Free Radic Res 2010;44:1064–1071.
   PubMed Web of Science ®Google Scholar
• Seet RC, Lee CY, Lim EC, Quek AM, Yeo LL, Huang SH, Halliwell B. Oxidative damage in dengue fever. Free Radic Biol Med 2009;47:375–380.
   PubMed Web of Science ®Google Scholar
• Seet RC, Lee CY, Lim EC, Tan JJ, Quek AM, Chong WL, et al. Oxidative damage in Parkinson disease: Measurement using accurate biomarkers. Free Radic Biol Med 2010;48: 560–566.
   PubMed Web of Science ®Google Scholar
• Seet RC, Lee CY, Loke WM, Huang SH, Huang H, Looi WF, et al. Biomarkers of oxidative damage in cigarette smokers: which biomarkers might reflect acute versus chronic oxidative stress? Free Radic Biol Med 2011;50:1787–1793.
   PubMed Web of Science ®Google Scholar
• Seet RC, Quek AM, Lim EC, Halliwell B. Biomarkers of oxidative damage are elevated among individuals with high cardiovascular risk: refining subject selection strategies for antioxidant trials. Free Radic Res 2013;47:283–290.
   PubMed Web of Science ®Google Scholar
• Ng MP, Lee JC, Loke WM, Yeo LL, Quek AM, Lim EC, et al. Does influenza a infection increase oxidative damage? Antioxid Redox Signal 2014;21:1025–1031.
   PubMedGoogle Scholar
• Seet RC, Lee CY, Chan BP, Sharma VK, Teoh HL, Venketasubramanian N, et al. Oxidative damage in ischemic stroke revealed using multiple biomarkers. Stroke 2011; 42:2326–2329.
   PubMedGoogle Scholar
• Tsikas D, Schwedhelm E, Fauler J, Gutzki FM, Mayatepek E, Frolich JC. Specific and rapid quantification of 8-iso-prostaglandin F2α in urine of healthy humans and patients with Zellweger syndrome by gas chromatography-tandem mass spectrometry. J Chromatogr B Biomed Sci Appl 1998;716:7–17.
   PubMed Web of Science ®Google Scholar
• Tsikas D, Schwedhelm E, Suchy MT, Niemann J, Gutzki FM, Erpenbeck VJ, et al. Divergence in urinary 8-iso-PGF2α (iPF2α-III, 15-F2t-IsoP) levels from gas chromatography-tandem mass spectrometry quantification after thin-layer chromatography and immunoaffinity column chromatography reveals heterogeneity of 8-iso-PGF2α. Possible methodological, mechanistic and clinical implications. J Chromatogr B Analyt Technol Biomed Life Sci 2003;794:237–255.
   PubMedGoogle Scholar
• Schwedhelm E, Tsikas D, Durand T, Gutzki FM, Guy A, Rossi JC, Frolich JC. Tandem mass spectrometric quantification of 8-iso-prostaglandin F2α and its metabolite 2,3-dinor-5,6-dihydro-8-iso-prostaglandin F2α in human urine. J Chromatogr B Biomed Sci Appl 2000;744:99–112.
   PubMed Web of Science ®Google Scholar
• Bachi A, Zuccato E, Baraldi M, Fanelli R, Chiabrando C. Measurement of urinary 8-Epi-prostaglandin F2alpha, a novel index of lipid peroxidation in vivo, by immunoaffinity extraction/gas chromatography-mass spectrometry. Basal levels in smokers and nonsmokers. Free Radic Biol Med 1996;20:619–624.
   PubMed Web of Science ®Google Scholar
• Dreissigacker U, Suchy MT, Maassen N, Tsikas D. Human plasma concentrations of malondialdehyde (MDA) and the F2-isoprostane 15(S)-8-iso-PGF2α may be markedly compromised by hemolysis: evidence by GC-MS/MS and potential analytical and biological ramifications. Clin Biochem 2010;43: 159–167.
   PubMed Web of Science ®Google Scholar
• Nourooz-Zadeh J, Gopaul NK, Barrow S, Mallet AI, Anggard EE. Analysis of F2-isoprostanes as indicators of non-enzymatic lipid peroxidation in vivo by gas chromatography-mass spectrometry: development of a solid-phase extraction procedure. J Chromatogr B Biomed Appl 1995;667: 199–208.
   PubMed Web of Science ®Google Scholar
• Signorini C, Comporti M, Giorgi G. Ion trap tandem mass spectrometric determination of F2-isoprostanes. J Mass Spectrom 2003;38:1067–1074.
   PubMed Web of Science ®Google Scholar
• Signorini C, De Felice C, Leoncini S, Giardini A, D’Esposito M, Filosa S, et al. F4-neuroprostanes mediate neurological severity in Rett syndrome. Clin Chim Acta 2011; 412:1399–1406.
   PubMed Web of Science ®Google Scholar
• De Felice C, Signorini C, Durand T, Ciccoli L, Leoncini S, D’Esposito M, et al. Partial rescue of Rett syndrome by omega-3 polyunsaturated fatty acids (PUFAs) oil. Genes Nutr 2012;7:447–458.
   PubMed Web of Science ®Google Scholar
• Nourooz-Zadeh J, Liu EH, Yhlen B, Anggard EE, Halliwell B. F4-isoprostanes as specific marker of docosahexaenoic acid peroxidation in Alzheimer's disease. J Neurochem 1999;72: 734–740.
   PubMed Web of Science ®Google Scholar
• Signorini C, Ciccoli L, Leoncini S, Carloni S, Perrone S, Comporti M, et al. Free iron, total F2-isoprostanes and total F4-neuroprostanes in a model of neonatal hypoxic-ischemic encephalopathy: neuroprotective effect of melatonin. J Pineal Res 2009;46:148–154.
   PubMed Web of Science ®Google Scholar
• Gladine C, Newman JW, Durand T, Pedersen TL, Galano JM, Demougeot C, et al. Lipid profiling following intake of the omega 3 fatty acid DHA identifies the peroxidized metabolites F4-neuroprostanes as the best predictors of atherosclerosis prevention. PLoS One 2014;9:e89393.
   PubMed Web of Science ®Google Scholar
• Mas E, Michel F, Guy A, Bultel V, Falquet Y, Chardon P, et al. Quantification of urinary F2-isoprostanes with 4(RS)-F4t-neuroprostane as an internal standard using gas chromatography-mass spectrometry Application to polytraumatized patients. J Chromatogr B Analyt Technol Biomed Life Sci 2008;872:133–140.
   PubMedGoogle Scholar
• Solberg R, Longini M, Proietti F, Vezzosi P, Saugstad OD, Buonocore G. Resuscitation with supplementary oxygen induces oxidative injury in the cerebral cortex. Free Radic Biol Med 2012;53:1061–1067.
   PubMed Web of Science ®Google Scholar
• Corcoran TB, Mas E, Barden AE, Durand T, Galano JM, Roberts LJ, et al. Are isofurans and neuroprostanes increased after subarachnoid hemorrhage and traumatic brain injury? Antioxid Redox Signal 2011;15:2663–2667.
   PubMed Web of Science ®Google Scholar
• De Felice C, Signorini C, Durand T, Oger C, Guy A, Bultel-Ponce V, et al. F2-dihomo-isoprostanes as potential early biomarkers of lipid oxidative damage in Rett syndrome. J Lipid Res 2011;52:2287–2297.
   PubMed Web of Science ®Google Scholar
• Korade Z, Xu L, Mirnics K, Porter NA. Lipid biomarkers of oxidative stress in a genetic mouse model of Smith-Lemli-Opitz syndrome. J Inherit Metab Dis 2013;36:113–122.
   PubMedGoogle Scholar
• Barden AE, Corcoran TB, Mas E, Durand T, Galano JM, Roberts LJ, et al. Is there a role for isofurans and neuroprostanes in pre-eclampsia and normal pregnancy? Antioxid Redox Signal 2012;16:165–169.
   PubMed Web of Science ®Google Scholar
• Matayatsuk C, Lee CY, Kalpravidh RW, Sirankapracha P, Wilairat P, Fucharoen S, Halliwell B. Elevated F2-isoprostanes in thalassemic patients. Free Radic Biol Med 2007;43: 1649–1655.
   PubMedGoogle Scholar
• Halliwell B, Lee CY. Using isoprostanes as biomarkers of oxidative stress: Some rarely-considered issues. Antioxid Redox Signal 2010;13:145–156.
   PubMed Web of Science ®Google Scholar
• Barden AE, Mas E, Croft KD, Phillips M, Mori TA. Minimizing artifactual elevation of lipid peroxidation products (F2-isoprostanes) in plasma during collection and storage. Anal Biochem 2014;449:129–131.
   PubMed Web of Science ®Google Scholar
• Proudfoot JM, Barden AE, Loke WM, Croft KD, Puddey IB, Mori TA. HDL is the major lipoprotein carrier of plasma F2-isoprostanes. J Lipid Res 2009;50:716–722.
   PubMed Web of Science ®Google Scholar
• Schuchardt JP, Schneider I, Meyer H, Neubronner J, von Schacky C, Hahn A. Incorporation of EPA and DHA into plasma phospholipids in response to different omega-3 fatty acid formulations - a comparative bioavailability study of fish oil vs. krill oil. Lipids Health Dis 2011;10:145.
   PubMed Web of Science ®Google Scholar
• Pasvogel AE, Miketova P, Moore IM. Cerebrospinal fluid phospholipid changes following traumatic brain injury. Biol Res Nurs 2008;10:113–120.
   PubMedGoogle Scholar
• Taylor AW, Bruno RS, Frei B, Traber MG. Benefits of prolonged gradient separation for high-performance liquid chromatography-tandem mass spectrometry quantitation of plasma total 15-series F-isoprostanes. Anal Biochem 2006;350:41–51.
   PubMed Web of Science ®Google Scholar
• Sircar D, Subbaiah PV. Isoprostane measurement in plasma and urine by liquid chromatography-mass spectrometry with one-step sample preparation. Clin Chem 2007;53: 251–258.
   PubMed Web of Science ®Google Scholar